Evidence map›Paper›PMID 33781979›Full record

ReviewHeart rhythm2021

Vein of Marshall ethanol infusion in the treatment of atrial fibrillation: From concept to clinical practice.

Miguel Valderrábano

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Heart rhythm, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07755072 (The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07755072 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting (MICS-CABG) on the Prevention of Postoperative New-Onset Atrial Fibrillation: A Multicenter, Prospective, Randomized, Triple-Blinded Study

TypeinterventionalSponsorPeking University Third HospitalRan2026 to 2028Enrolled628ConditionsPostoperative Atrial FibrillationArmsMICS-CABG combined with excision of the Ligament of Marshall
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. A novel technique for vein of Marshall blood sampling and its application in assessing atrial remodeling in atrial fibrillation.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Miguel ValderrábanoDivision of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center and Houston Methodist Research Institute, The Methodist Hospital, Houston, Texas. Electronic address: MValderrabano@houstonmethodist.org.
Houston Methodist · US

Funding

Vein of Marshall Ethanol Infusion for Persistent Atrial FibrillationR01HL115003 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI VALDERRABANO, MIGUEL · 2013 to 2017
$3.6M
Vein of Marshall as a therapeutic agent in the treatment of atrial fibrillationR21HL097305 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI VALDERRABANO, MIGUEL · 2010 to 2011
$424k
NHLBI NIH HHS R01 HL115003NHLBI NIH HHS R21 HL097305
6 · The paper itself

Abstract

The vein of Marshall (VOM) contains innervation, myocardial connections, and arrhythmogenic foci that make it an attractive target in catheter ablation of atrial fibrillation (AF). Additionally, it co-localizes with the mitral isthmus, which is critical to sustain perimitral flutter, and is a true atrial vein that communicates with underlying myocardium. Retrograde balloon cannulation of the VOM from the coronary sinus is feasible and allows for ethanol delivery, which results in rapid ablation of neighboring myocardium and its innervation. Here we review the body of work performed over a span of 13 years, from the inception of the technique, to its preclinical validation, to demonstration of its ablative and denervation effects, and finally to completion of a randomized clinical trial demonstrating favorable outcomes, improving rhythm control in catheter ablation of persistent AF.

Indexed as

Atrial FibrillationEthanolHeart RateHumansInfusions, IntravenousEthanolAblationAlcoholAtrial fibrillationEthanolVein of Marshall

Identifiers

PMID33781979
PMCPMC8254799
OpenAlexW3151558451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.